Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance

J Neurosci Res. 2000 Jan 15;59(2):238-46. doi: 10.1002/(sici)1097-4547(20000115)59:2<238::aid-jnr10>3.0.co;2-g.

Abstract

A short duration of ischemia (i.e., ischemic preconditioning) was shown to result in significant tolerance to subsequent ischemic injury. Since previous reports suggest that interleukin-1beta (IL-1beta) may be involved in both ischemic damage and neuroprotection, the present work examined the expression of IL-1beta mRNA in cortical brain tissue after an established preconditioning (PC) stimulus known to produce significant brain tolerance to focal stroke after 1-7 days. Significant induction of IL-1beta mRNA was observed in the ipsilateral cortex at 6 hr (87+/-9 copies of the mRNA per microgram of brain tissue compared to 16+/-5 copies in sham-operated samples, P < 0.001, n = 4) and 8 hr (46+/-4 copies, P < 0.01, n = 4) after PC by means of real-time Taqman polymerase chain reaction (PCR). The peak expression of IL-1beta mRNA after PC was significantly (P < 0.01) lower than that after permanent occlusion of the middle cerebral artery (MCAO), i.e., 87+/-9 and 546+/-92 copies of RNA per microgram tissue at peak levels for PC and focal stroke, respectively. Immunohistochemistry studies revealed a parallel induction of IL-1beta in the ipsilateral cortex after PC. The maximal expression of IL-1beta was observed during the first week post-PC, showing marked parallelism with the duration of ischemic tolerance. These data suggest that the significant but low levels of IL-1beta induction after PC may contribute to ischemic brain tolerance.

MeSH terms

  • Animals
  • Astrocytes / physiology
  • Brain Ischemia / genetics*
  • Brain Ischemia / physiopathology*
  • Cerebral Cortex / blood supply
  • Cerebral Cortex / chemistry
  • Cerebral Cortex / physiology
  • DNA Primers
  • Fluorescent Antibody Technique
  • Gene Expression / genetics
  • Interleukin-1 / analysis
  • Interleukin-1 / genetics*
  • Ischemic Preconditioning
  • Polymerase Chain Reaction / methods*
  • RNA, Messenger / analysis
  • Rats
  • Stroke / genetics
  • Stroke / physiopathology
  • Taq Polymerase
  • Time Factors

Substances

  • DNA Primers
  • Interleukin-1
  • RNA, Messenger
  • Taq Polymerase